Zdeněk Fryšák

993 total citations
59 papers, 647 citations indexed

About

Zdeněk Fryšák is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Epidemiology. According to data from OpenAlex, Zdeněk Fryšák has authored 59 papers receiving a total of 647 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Endocrinology, Diabetes and Metabolism, 24 papers in Surgery and 12 papers in Epidemiology. Recurrent topics in Zdeněk Fryšák's work include Pituitary Gland Disorders and Treatments (15 papers), Adrenal and Paraganglionic Tumors (14 papers) and Cancer, Hypoxia, and Metabolism (10 papers). Zdeněk Fryšák is often cited by papers focused on Pituitary Gland Disorders and Treatments (15 papers), Adrenal and Paraganglionic Tumors (14 papers) and Cancer, Hypoxia, and Metabolism (10 papers). Zdeněk Fryšák collaborates with scholars based in Czechia, United States and Slovakia. Zdeněk Fryšák's co-authors include David Karásek, Karel Pacák, Jiřina Zapletalová, Jan Schovánek, Miroslav Vaverka, Miroslav Souček, Constantine A. Stratakis, Igor Hartmann, Ľubica Cibičková and J. Václavík and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Clinical Cancer Research.

In The Last Decade

Zdeněk Fryšák

54 papers receiving 630 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zdeněk Fryšák Czechia 13 364 323 206 95 78 59 647
D. Drui France 18 461 1.3× 416 1.3× 211 1.0× 49 0.5× 93 1.2× 63 839
Vitaly Kantorovich United States 10 294 0.8× 359 1.1× 219 1.1× 58 0.6× 43 0.6× 27 704
A. Pia Italy 18 817 2.2× 750 2.3× 265 1.3× 74 0.8× 99 1.3× 26 1.1k
Marianne S. Elston New Zealand 18 505 1.4× 322 1.0× 121 0.6× 112 1.2× 146 1.9× 59 972
Stéphanie Espiard France 16 450 1.2× 454 1.4× 157 0.8× 47 0.5× 34 0.4× 50 772
Lino Furlani Italy 8 486 1.3× 371 1.1× 130 0.6× 31 0.3× 69 0.9× 11 698
Leslie R. Sheeler United States 17 662 1.8× 452 1.4× 104 0.5× 81 0.9× 145 1.9× 35 981
N. Thalassinos Greece 17 569 1.6× 339 1.0× 62 0.3× 53 0.6× 90 1.2× 29 786
Simon Rajaratnam India 15 413 1.1× 241 0.7× 52 0.3× 49 0.5× 135 1.7× 57 597
Meg Keil United States 16 670 1.8× 636 2.0× 56 0.3× 88 0.9× 73 0.9× 39 1.1k

Countries citing papers authored by Zdeněk Fryšák

Since Specialization
Citations

This map shows the geographic impact of Zdeněk Fryšák's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zdeněk Fryšák with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zdeněk Fryšák more than expected).

Fields of papers citing papers by Zdeněk Fryšák

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zdeněk Fryšák. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zdeněk Fryšák. The network helps show where Zdeněk Fryšák may publish in the future.

Co-authorship network of co-authors of Zdeněk Fryšák

This figure shows the co-authorship network connecting the top 25 collaborators of Zdeněk Fryšák. A scholar is included among the top collaborators of Zdeněk Fryšák based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zdeněk Fryšák. Zdeněk Fryšák is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zethoven, Magnus, Luciano G. Martelotto, Andrew Pattison, et al.. (2022). Single-nuclei and bulk-tissue gene-expression analysis of pheochromocytoma and paraganglioma links disease subtypes with tumor microenvironment. Nature Communications. 13(1). 6262–6262. 26 indexed citations
2.
Schovánek, Jan, et al.. (2020). Differential diagnosis of hypoglycemia. Vnitřní lékařství. 66(2). 129–133. 1 indexed citations
3.
Schovánek, Jan, Ľubica Cibičková, Zbyněk Tüdös, et al.. (2019). Hypoglycemia as a Symptom of Neoplastic Disease, with a focus on Insulin-like Growth Factors Producing Tumors. Journal of Cancer. 10(26). 6475–6480. 12 indexed citations
4.
Pang, Ying, Yanxin Lu, Veronika Caisová, et al.. (2018). Targeting NAD+/PARP DNA Repair Pathway as a Novel Therapeutic Approach to SDHB -Mutated Cluster I Pheochromocytoma and Paraganglioma. Clinical Cancer Research. 24(14). 3423–3432. 61 indexed citations
5.
Schovánek, Jan, et al.. (2017). Commentary on the new guidelines for endocrine orbitopathy. Interní medicína pro praxi. 19(5). 246–250. 1 indexed citations
6.
Fryšák, Zdeněk, et al.. (2017). Ethanol sclerotherapy of thyroid cysts - an effective alternative to surgery. Interní medicína pro praxi. 19(4). 198–202.
7.
Hartmann, Igor, et al.. (2016). Adrenocortical carcinoma. Urologie pro praxi. 17(5). 206–209.
8.
Fryšák, Zdeněk, Jan Schovánek, Maurizio Iacobone, & David Karásek. (2015). Insulin-like Growth Factors in a clinical setting: Review of IGF-I. Biomedical Papers. 159(3). 347–351. 23 indexed citations
9.
Študentová, Hana, Bohuslav Melichar, Milan Kamínek, et al.. (2015). Brain metastases of parathyroid carcinoma: Review of the literature and a case report. Biomedical Papers. 159(3). 360–365. 3 indexed citations
10.
Hartmann, Igor, Aleš Vidlář, J. Václavík, et al.. (2014). Outcomes of adrenalectomy in patients with primary hyperaldosteronism - a single centre experience. Biomedical Papers. 158(4). 583–590. 4 indexed citations
12.
Karásek, David, et al.. (2014). Ultrasound-guided percutaneous ethanol injection of small and medium-sized thyroid cysts with relatively small amounts of ethanol. Biomedical Papers. 159(3). 417–421. 11 indexed citations
13.
Fryšák, Zdeněk, et al.. (2013). What is the benefit of screening for thyroid function in pregnant women in the detection of newly diagnosed thyropathies?. Biomedical Papers. 157(4). 358–362. 2 indexed citations
14.
Fryšák, Zdeněk, et al.. (2013). Secondary hypertension and hirsutism as a clinical manifestation of tumor duplicity. Biomedical Papers. 159(1). 163–165. 2 indexed citations
15.
Karásek, David, Urvi A. Shah, Zdeněk Fryšák, Constantine A. Stratakis, & Karel Pacák. (2012). An update on the genetics of pheochromocytoma. Journal of Human Hypertension. 27(3). 141–147. 36 indexed citations
16.
Karásek, David, et al.. (2012). Prehypertension in dyslipidemic individuals; relationship to metabolic parameters and intima-media thickness. Biomedical Papers. 157(1). 41–49. 8 indexed citations
17.
Karásek, David, et al.. (2011). Soluble intercellular cell adhesion molecule-1 and vascular cell adhesion molecule-1 in asymptomatic dyslipidemic subjects.. PubMed. 30(5). 441–50. 5 indexed citations
18.
Szotkowski, Tomáš, et al.. (2002). [Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome (TTP-HUS) leading to the diagnosis of Wilson's disease].. PubMed. 48(4). 353–6. 2 indexed citations
19.
Aujeský, R, et al.. (2001). [Effect of portosystemic anastomosis on the degree of splenic inhibition].. PubMed. 80(5). 246–9. 1 indexed citations
20.
Fryšák, Zdeněk, et al.. (1985). [The effect of colchicine administration on the biochemical picture in liver cirrhosis].. PubMed. 31(9). 862–9. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026